Grzyby lecznicze i jadalne. Cz. II. Immunologicznie aktywne substancje grzybów leczniczych i jadalnych

• Autorzy: Busch E. , Von Rekowski R.W. , Altenbach H.J. , Moelleken H. , Burczyk J. , Malinowska E. , Krzyczkowski W.

Warianty tytułu

EN

Therapeutic and edible mushrooms. Part II. Immunological active substances of higher edible and therapeutic mushrooms

• Języki publikacji: PL

Abstrakty

PL

Omówiono stan badań dotyczący aktywności terapeutycznej 8 ważniejszych grzybów leczniczych z rodzaju: Lentinus, Grifolia, Pleurotus, Flammulina, Agaricus, Hirneola (Auricularia) oraz Ganoderma. W szczególności omówiono działanie immunostymulujace i przeciwnowotworowe. Za wspomniane działania są głównie odpowiedzialne glikoproteiny Ulub polisacharydy zazwyczaj typu ß-l,3-glukanu. Przedstawiono przykłady hodowli przemysłowej wspomnianych grzybów.

EN

The publication gives a review of therapeutic activities of 8 edible mushrooms. These are members of the genus: Lentinus, Grifolia, Pleurotus, Flammulina, Agaricus, Hirneola (Auricularia) and Ganoderma. Particularly discussed are the immunomodulatory and antineoplastic acitivities. These are related mainly to ß-l,3-glucans, which act on the immune system. In some cases the large scale production of mushrooms was shown.

Słowa kluczowe

PL

grzyby jadalne; grzyby lecznicze; substancje biologicznie czynne; glikoproteiny; dzialanie przeciwnowotworowe; immunomodulatory; wielocukry; beta-1,3-glukany

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2010
• Tom: 37
• Numer: 2
• Opis fizyczny: s.105-114,tab.,bibliogr.

Twórcy

autor

Busch E.

• Mykomax GmbH, Wuppertal

autor

Von Rekowski R.W.

autor

Altenbach H.J.

autor

Moelleken H.

autor

Burczyk J.

autor

Malinowska E.

autor

Krzyczkowski W.

Bibliografia

• 1. Ahn W.S. i wsp.: Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricusblazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. International Journal of Gynecological Cancer, 2004, 14(4), 589-594.
• 2. Angeli J.P i wsp.: Protective effects of beta-glucan extracted from Agaricus brasiliensis agaist chemically induced DNA damage in human lymphocytes. Cell Biology and Toxicology, 2006, 22(4), 285-291.
• 3. Barbisan L.F. i wsp.: Effects of crude extracts of Agaricus blazei on DNA damage and on rat liver carcinogenesis induced by diethylnitrosamine. Genetics and Molecular Research. 2003, 2(3), 295-308.
• 4. Chang S.T.: Products of medicinal mushrooms as a good source of dietary supplements. The International Society For Mushroom Science, August 2001.
• 6. Delmanto R.D. i wsp.: Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide. Mutation Research, 2001, 496(1-2), 15-21.
• 8. Dong O., Jia L.M., Fang J.N.: A beta D-glucan isolated from the fruiting bodies of Hericium erinaceus and the aqueous conformation. Carbohydrate Research, 2006, 341(6), 791-795.
• 9. Ellertsen L.K. .: Effect of a medicinal extract from Agarius blazei Murill on gene expression in a human momocyte cell line as examined by microarrays and immuno assays. International Immunopharmacology, 2006, 6(2), 133-143.
• 11. Jeong S.C. i wsp.: Production of an anti-complement exo-polymer produced by Auricularia auricula-judae in submerged culture. Biotechnology Letters, 2004, 26 (11), 923-927.
• 12. Jia L.M. i wsp.: Structural investigations of a novel tham- noglucogalactan isolated from the fruiting bodies of the fungus Hericium erinaceus. Carbohydrate Research, 2004, 339(16), 2667-2671.
• 13. Jin C.Y. i wsp.: Induction of G2/M arrest and apoptosis in human gastric epithelial AGS cells by aqueous extract of Agarius balzei. Oncology Reports, 2006, 16, 1349-1355.
• 14. Kasai H. i wsp.: IL-12 production induced by Agaricus blazei Fraction H (ABH) involves tolllike receptor (TLR). Evidence-based Complementary and Alternative Medicine, 2004, 1(3), 259-267.
• 15. Kawamura M. i wsp.: Antithetical effects of hemicellu- lase-treated Agaricus blazei on the maturation of murine bone-marrow-derived dendritic cells. Immunology, 2005, 114(3), 397-409.
• 16. Kim Y.W. i wsp. Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnology Letters, 2005, 27(7), 483-487.
• 17. Kim G.Y. i wsp.: Effect of water-soluble proteoglycan isolated from Agaricus blazei on the maturation of murine bone marrow-derived dendritic cells. International Immunopharmacology, 2005, 5(10), 1523-1532.
• 18. Kobayashi H. i wsp.: Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on and peritoneal disseminated metastasis in mouse model. Journal of Cancer Research and Clinical Oncology, 2005, 131(8), 527-538.
• 20. Lindequist L., Niedermeyer T.H.J., Jiilich W.-D.: The pharmacological potential of mushrooms. Evidence-based Complementary and Alternative Medicine, 2005, 2(3), 285-299.
• 21. Liu C. i wsp.: Study on the antitumor effects of fungus polysaccharides compounds. J Hyg Res. 2000, 29(3), 178-180.
• 25. Mukai H. i wsp.: An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients. Japanese Journal of Clinical Oncology, 2006, 36(12), 808-810.
• 26. Nagaoka MH. i wsp.: Measurement of a genotoxic hydrazine, agaritine, and its derivatives by HPLC with fluorescence derivatization in the Agaricus mushroom and its products. Chemical and Pharmaceutical Bulletin, 2006, 54(6), 922-924.
• 29. Takeujchi H., He R, Mooi L.Y.: Reductive effect of hot-water extracts from woody ear (Auricularia auricula-judae Quel.) on food intake and blood glucose concentration in genetically diabetic KK-Ay mice. Journal of Nutrition Science and Vitaminology, 2004, 50(4), 300-304.
• 31. Wang J.C. i wsp.: Antimutagenicity of extracts of Hericium erinaceus. Kaohsiung Journal of Medical Sciences, 2001b, 17(5), 230-238.
• 32. Wang J.C. i wsp.: Antitumor and immunoenhancing activities of polysaccharide from culture broth of Hericium spp. Kaohsiung Journal of Medical Sciences, 2001a, 17(9), 461- 467.
• 33. Wasser S.P.: Medicinal mushrooms as a source of antitumor and immu- nomodulating polysaccharides. Applied Microbiology and Biotechnology, 2002, 60, 258-274.
• 34. Wasser S.R: Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology, 2002, 60, 258-274.
• 36. Yang B.K., Park J.B., Song C.H.: Hypolipidemic effect of an Exobiopolymer produced from a submerged mycelial culture of Hericium erinaceus. Bioscience, Biotechnology, and Biochemistry, 2003, 67(6), 1292-1298.
• 38. Zhang A.O. i wsp.: Structural elucidation of a novel fucogalactan that contains 3-O-methyl rhamnose isolated from the 39 fruiting bodies of the fungus Hericium erinaceus. Carbohydrate Research, 2006, 341(5), 645-649.
• 39. Zhong M., Tai A., Yamamoto I.: In vitro augmentation of natural killer cell activity and interferon-gamma production in murine spleen cells with Agaricus blazei fruiting body fractions. Bioscience, Biotechnology, and Biochemistry, 2005, 69(12), 2466-2469.
• 40. Chang S-T.: Overview of mushroom cultivation and utilization as functional foods. In: Cheung EC.K. (ed) Mushrooms as functional foods. Wiley, Hoboken , New Jersey, 2008, pp. 1-33.
• 41. Kwieciński A.: Reishi - nadzieja współczesnej medycyny. Wydawnictwo Kwieciński, Jaworze, 2004.
• 43. Ooi VE., Liu F.: Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Current Medicinal Chemistry, 2000, 7, 715-729.
• 44. Gao Y, Chan E., Zhou S.: Immunomodulating activities of Ganoderma, a mushroom with medicinal properties. Food Reviews International, 2004, 20, 123-161.
• 45. Cheung PC.K.: Mushrooms as functional foods. Wiley, Hoboken , New Jersey, 2008, 151.
• 46. Lin Z.B.: Cellular and molecular mechanisms of immunomodulation by Ganoderma lucidum. Journal of Pharmacological Sciences, 2005, 99, 144-153.
• 47. Ooi L-S., Ooi VE.C., Fung M.C.: Induction of gene expression of immunomodulatory cytokines in the Mouse by a polysaccharide from Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetidae). International Journal of Medicinal Mushrooms, 2002, 4, 27-35.
• 48. Lee S.S. i wsp.: Antitumor effects of polysaccharides of Ganoderma lucidum (Curt.:Fr.) P. Karst (Ling Zhi, Reishi mushroom) (Aphyllophoromycetidae). International Journal of Medicinal Mushrooms, 2003, 5, 1-16.
• 49. Gao Y. i wsp.: Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice. Immunological Investigations, 2005, 34, 171-198.
• 51. Cao Q.Z., Lin Z.B.: Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sciences, 2006, 78, 1457-1463